English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 63 Help

Selected(0)Clear Items/Page:    Sort:
Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies Journal article
Huang, Jihan, Shi, Ruipeng, Chen, Feiyu, Zheng, Jinbin, Wang, Ning, Li, Ran, Wang, Yulin, Yang, Tao, Feng, Yibin, Zhong, Zhangfeng. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies[J]. Phytomedicine, 2024, 133, 155905.
Authors:  Huang, Jihan;  Shi, Ruipeng;  Chen, Feiyu;  Zheng, Jinbin;  Wang, Ning; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:6.7/6.2 | Submit date：2024/09/03
Big Data  Hepatocellular Carcinoma  Network Pharmacology  Rna Sequencing  Xianglian Pill  
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC[J]. Hepatology, 2024, 80(2), 330-345.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:12.9/15.5 | Submit date：2024/08/05
Hepatocellular-carcinoma  Up-regulation  Inhibition  Activation  Growth  Cells  
Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors Journal article
Zou, Huimin, Ge, Ying, Chen, Wenge, Yao, Dongning, Oi Lam Ung, Carolina, Lai, Yunfeng, Hu, Hao. Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors[J]. International Immunopharmacology, 2024, 132, 111947.
Authors:  Zou, Huimin;  Ge, Ying;  Chen, Wenge;  Yao, Dongning;  Oi Lam Ung, Carolina; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:4.8/5.0 | Submit date：2024/05/16
Camrelizumab  China  Hepatocellular Carcinoma  Programmed Cell Death Protein-1 Inhibitor  Tislelizumab  
Rhein-based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization Journal article
Liang, Xiaoliu, Liu, Hui, Chen, Hu, Peng, Xuqi, Li, Zhenjie, Teng, Minglei, Peng, Yisheng, Li, Jiwei, Ding, Linyu, Mao, Jingsong, Chu, Chengchao, Cheng, Hongwei, Liu, Gang. Rhein-based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization[J]. Aggregate, 2024, e552.
Authors:  Liang, Xiaoliu;  Liu, Hui;  Chen, Hu;  Peng, Xuqi;  Li, Zhenjie; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9 | Submit date：2024/05/16
Glycolysis  Hepatocellular Carcinoma  Immunoembolization  Pickering Emulsion  Transarterial Chemoembolization  
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma Journal article
Zhang, Qi Yi, Ding, Wen, Mo, Jian Shan, Ou-yang, Shu Min, Lin, Zi You, Peng, Ke Ren, Liu, Guo Pin, Lu, Jin Jian, Yue, Pei Bin, Lei, Jin Ping, Wang, Yan Dong, Zhang, Xiao Lei. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma[J]. ACTA PHARMACOLOGICA SINICA, 2024.
Authors:  Zhang, Qi Yi;  Ding, Wen;  Mo, Jian Shan;  Ou-yang, Shu Min;  Lin, Zi You; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:6.9/7.6 | Submit date：2024/05/16
Acquired Sorafenib-resistance  Antisense Oligonucleotide  Hepatocellular Carcinoma  Stat3  
A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability Journal article
Wang, Ling, Wang, Xueliang, Chen, Feng, Song, Ying Qi, Nao, Sang Cuo, Chan, Daniel Shiu Hin, Wong, Chun Yuen, Wang, Wanhe, Leung, Chung Hang. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability[J]. European Journal of Medicinal Chemistry, 2024, 264, 115995.
Authors:  Wang, Ling;  Wang, Xueliang;  Chen, Feng;  Song, Ying Qi;  Nao, Sang Cuo; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:6.0/6.1 | Submit date：2024/02/22
Glycyrrhetinic Acid (Ga)  Hepatocellular Carcinoma  Iridium(Iii) Complex  Mitochondrial Targeting  Nir Imaging  Theranostic  
Combination strategies for first-line treatment of patients with unresectable hepatocellular carcinoma: prospect of natural products Other
2024-01-01
Authors:  ZHANG, Lele;  LU, Jinjian
Favorite | TC[WOS]:4 TC[Scopus]:4 | Submit date：2024/02/22
Combination Strategies  Immunotherapy  Natural Products  Pd-1/pd-l1  Unresectable Hepatocellular Carcinoma  
Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展 Journal article
Li,Shuang, Liu,Zherui, Lu,Yinying. Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li,Shuang;  Liu,Zherui;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/03
Carcinoma, Hepatocellular  Chimeric Antigen  Receptors  T-lymphocytes  Therapeutics  
Molecular mechanisms of autophagy and implications in liver diseases Journal article
Wu,Yuankai, Tan,Hayden Weng Siong, Lin,Jin Yi, Shen,Han Ming, Wang,Haihe, Lu,Guang. Molecular mechanisms of autophagy and implications in liver diseases[J]. Liver Research, 2023, 7(1), 56-70.
Authors:  Wu,Yuankai;  Tan,Hayden Weng Siong;  Lin,Jin Yi;  Shen,Han Ming;  Wang,Haihe; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:2.0/0 | Submit date：2023/08/03
Acetaminophen (Apap)  Alcohol-related Liver Disease (Arld)  Autophagy  Hepatocellular Carcinoma (Hcc)  Non-alcoholic Fatty Liver Disease (Nafld)  Viral Hepatitis  
Thermoacoustic Imaging-Guided Thermo-Chemotherapy for Hepatocellular Carcinoma Sensitized by a Microwave-Responsive Nitric Oxide Nanogenerator Journal article
Wen, Liewei, Liu, Hongyi, Hu, Cong, Wei, Zixuan, Meng, Ya, Lu, Cuixia, Su, Yanhong, Lu, Ligong, Liang, Hui, Xu, Qingbo, Zhan, Meixiao. Thermoacoustic Imaging-Guided Thermo-Chemotherapy for Hepatocellular Carcinoma Sensitized by a Microwave-Responsive Nitric Oxide Nanogenerator[J]. ACS Applied Materials and Interfaces, 2023, 15(8), 10477-10491.
Authors:  Wen, Liewei;  Liu, Hongyi;  Hu, Cong;  Wei, Zixuan;  Meng, Ya; et al.
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:8.3/8.7 | Submit date：2023/04/03
Chemotherapy  Hepatocellular Carcinoma  Lipid Peroxidation  Microwave Thermotherapy  Nitric Oxide  Thermoacoustic Imaging